Budd GT - Search Results

1

Signal transduction abnormalities in T lymphocytes from patients with advanced renal carcinoma: clinical relevance and effects of cytokine therapy.

Bukowski RM, Rayman P, Uzzo R, Bloom T, Sandstrom K, Peereboom D, Olencki T, Budd GT, McLain D, Elson P, Novick A, Finke JH. Bukowski RM, et al. Among authors: budd gt. Clin Cancer Res. 1998 Oct;4(10):2337-47. Clin Cancer Res. 1998. PMID: 9796963 Clinical Trial.

2

Phase I trial of high-dose bolus interleukin-2 and interferon alfa-2a in patients with metastatic malignancy.

Budd GT, Murthy S, Finke J, Sergi J, Gibson V, Medendorp S, Barna B, Boyett J, Bukowski RM. Budd GT, et al. J Clin Oncol. 1992 May;10(5):804-9. doi: 10.1200/JCO.1992.10.5.804. J Clin Oncol. 1992. PMID: 1569452 Clinical Trial.

3

A phase I trial of 5-fluorouracil, folinic acid, and alpha-2a-interferon in patients with metastatic colorectal carcinoma.

Bukowski RM, Inoshita G, Yalavarthi P, Murthy S, Gibson V, Budd GT, Sergi JS, Bauer L, Prestifilippo J. Bukowski RM, et al. Among authors: budd gt. Cancer. 1992 Feb 15;69(4):889-92. doi: 10.1002/1097-0142(19920215)69:4<889::aid-cncr2820690409>3.0.co;2-r. Cancer. 1992. PMID: 1735080 Clinical Trial.

4

Phase I trial of continuous infusion interleukin-2 and doxorubicin in patients with refractory malignancies.

Bukowski RM, Sergi JS, Budd GT, Murthy S, Tubbs R, Gibson V, Bauer L, Stanley J, Gautam S, Finke J. Bukowski RM, et al. Among authors: budd gt. J Immunother (1991). 1991 Dec;10(6):432-9. doi: 10.1097/00002371-199112000-00007. J Immunother (1991). 1991. PMID: 1768677

5

Clinical results and characterization of tumor-infiltrating lymphocytes with or without recombinant interleukin 2 in human metastatic renal cell carcinoma.

Bukowski RM, Sharfman W, Murthy S, Rayman P, Tubbs R, Alexander J, Budd GT, Sergi JS, Bauer L, Gibson V, et al. Bukowski RM, et al. Among authors: budd gt. Cancer Res. 1991 Aug 15;51(16):4199-205. Cancer Res. 1991. PMID: 1868441 Clinical Trial.

6

A Southwest Oncology Group phase II Trial of recombinant tumor necrosis factor in metastatic breast cancer.

Budd GT, Green S, Baker LH, Hersh EP, Weick JK, Osborne CK. Budd GT, et al. Cancer. 1991 Oct 15;68(8):1694-5. doi: 10.1002/1097-0142(19911015)68:8<1694::aid-cncr2820680806>3.0.co;2-k. Cancer. 1991. PMID: 1913510 Clinical Trial.

7

Phase I trial of natural human interferon beta in metastatic malignancy.

Bukowski RM, Sergi JS, Sharfman WJ, Budd GT, Murthy S, Barna B, Medendorp SV, Yen-Lieberman B, Gibson V, Bauer L, et al. Bukowski RM, et al. Among authors: budd gt. Cancer Res. 1991 Feb 1;51(3):836-40. Cancer Res. 1991. PMID: 1988123 Clinical Trial.

8

Phase I trial of continuous infusion recombinant interleukin-2 and intermittent recombinant interferon-alpha 2a: clinical effects.

Bukowski RM, Murthy S, Sergi J, Budd GT, McKeever S, Medendorp SV, Tubbs R, Gibson V, Finke J. Bukowski RM, et al. Among authors: budd gt. J Biol Response Mod. 1990 Dec;9(6):538-45. J Biol Response Mod. 1990. PMID: 2074440 Clinical Trial.

9

Phase I trial of dipyridamole with 5-fluorouracil and folinic acid.

Budd GT, Jayaraj A, Grabowski D, Adelstein D, Bauer L, Boyett J, Bukowski R, Murthy S, Weick J. Budd GT, et al. Cancer Res. 1990 Nov 15;50(22):7206-11. Cancer Res. 1990. PMID: 2224854 Clinical Trial.

10

High-dose cisplatin for metastatic soft tissue sarcoma.

Budd GT, Metch B, Balcerzak SP, Fletcher WS, Baker LH, Mortimer JE. Budd GT, et al. Cancer. 1990 Feb 15;65(4):866-9. doi: 10.1002/1097-0142(19900215)65:4<866::aid-cncr2820650406>3.0.co;2-#. Cancer. 1990. PMID: 2297655

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

193 results

Search Page

Filters